Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yimitasvir + Sofosbuvir in Chronic HCV Genotype 1
NCT03487107Phase 3Completed
- Sponsor
- Sunshine Lake Pharma
- Start
- Apr 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of yimitasvir in hepatitis C (HCV), sponsored by Sunshine Lake Pharma. Started Apr 2018; status: completed.
02
Drugs
yimitasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03487107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03487107.